AU2001239921A1 - Antibody inhibiting the binding between GP120 and DC-SIGN and screening methods - Google Patents

Antibody inhibiting the binding between GP120 and DC-SIGN and screening methods

Info

Publication number
AU2001239921A1
AU2001239921A1 AU2001239921A AU2001239921A AU2001239921A1 AU 2001239921 A1 AU2001239921 A1 AU 2001239921A1 AU 2001239921 A AU2001239921 A AU 2001239921A AU 2001239921 A AU2001239921 A AU 2001239921A AU 2001239921 A1 AU2001239921 A1 AU 2001239921A1
Authority
AU
Australia
Prior art keywords
sign
binding
screening methods
antibody inhibiting
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001239921A
Other versions
AU2001239921B2 (en
Inventor
Teunis Geijtenbeek
Douglas Kwon
Dan R. Littman
Yvette Van Kooyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Radboud University Nijmegen
New York University NYU
Original Assignee
Radboud University Nijmegen
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/517,605 external-priority patent/US6391567B1/en
Application filed by Radboud University Nijmegen, New York University NYU filed Critical Radboud University Nijmegen
Publication of AU2001239921A1 publication Critical patent/AU2001239921A1/en
Application granted granted Critical
Publication of AU2001239921B2 publication Critical patent/AU2001239921B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001239921A 2000-03-02 2001-02-28 Antibody inhibiting the binding between GP120 and DC-SIGN and screening methods Ceased AU2001239921B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/517,605 2000-03-02
US09/517,605 US6391567B1 (en) 2000-03-02 2000-03-02 Identifying compounds inhibiting DC-sign facilitation of HIV into cells
PCT/US2001/006322 WO2001064752A2 (en) 2000-03-02 2001-02-28 Antibody inhibiting the binding between gp120 and dc-sign and screening methods

Publications (2)

Publication Number Publication Date
AU2001239921A1 true AU2001239921A1 (en) 2001-11-22
AU2001239921B2 AU2001239921B2 (en) 2006-11-23

Family

ID=24060480

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001239921A Ceased AU2001239921B2 (en) 2000-03-02 2001-02-28 Antibody inhibiting the binding between GP120 and DC-SIGN and screening methods
AU3992101A Pending AU3992101A (en) 2000-03-02 2001-02-28 Methods of using a facilitator of retroviral entry into cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU3992101A Pending AU3992101A (en) 2000-03-02 2001-02-28 Methods of using a facilitator of retroviral entry into cells

Country Status (6)

Country Link
US (2) US6391567B1 (en)
EP (1) EP1263789A2 (en)
JP (1) JP2004536777A (en)
AU (2) AU2001239921B2 (en)
CA (1) CA2402054A1 (en)
WO (1) WO2001064752A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208152B2 (en) 1999-11-24 2007-04-24 Millennium Pharmaceuticals, Inc. Antibodies for “Bonzo” chemokine receptor and therapeutic uses thereof
US6319675B1 (en) 1999-11-24 2001-11-20 Millennium Pharmaceuticals, Inc. Methods for detecting and/or identifying agents which bind and/or modulate function of “bonzo” chemokine receptor
US7022323B2 (en) * 2001-06-26 2006-04-04 Progenics Pharmaceuticals, Inc. Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
US20030232745A1 (en) * 2001-06-26 2003-12-18 Olson William C. Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection
US20040142891A1 (en) * 2001-08-16 2004-07-22 Universiteit Utrecht Genes involved in immune related responses observed with asthma
US20050221291A1 (en) * 2002-05-03 2005-10-06 Board Of Regents, The University Of Texas System Dc-sign isoforms, related compositions and methods for their use in disease therapy
ES2197826B1 (en) * 2002-06-21 2005-04-01 Consejo Superior De Investigaciones Cientificas THERAPEUTIC COMPOUND AGAINST INFECTION WITH LEISHMANIA AND ITS USE.
US7427469B2 (en) * 2002-11-05 2008-09-23 Institut Pasteur Method of treating cytomegalovirus with DC-SIGN blockers
ATE428437T1 (en) * 2002-11-05 2009-05-15 Pasteur Institut DC-SIGN BLOCKERS AND THEIR USE TO PREVENT OR TREAT VIRAL INFECTIONS
WO2005000219A2 (en) * 2003-05-28 2005-01-06 The Board Of Trustees Of The University Of Illinois Composition for blocking hiv binding to dendritic cells and methods of use thereof
GB0318247D0 (en) * 2003-08-05 2003-09-10 Royal Veterinary College Antigen delivery system
WO2005040823A1 (en) * 2003-10-24 2005-05-06 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 15 (gpr15)
US8202523B2 (en) * 2005-09-22 2012-06-19 ProSci, Inc. Glycosylated polypeptides produced in yeast mutants and methods of use thereof
US20090214510A1 (en) * 2006-02-21 2009-08-27 Government Of The Us As Represented By The Secretary, Department Of Health And Human Services Broad Spectrum Antiviral Compositions
AU2008319384A1 (en) 2007-10-29 2009-05-07 Virginia Tech Intellectual Properties, Inc. Porcine DC-SIGN , ICAM-3 and LSECtin and uses thereof
WO2014151771A1 (en) * 2013-03-14 2014-09-25 The J. David Gladstone Institutes Compositions and methods for treating an immunodeficiency virus infection
WO2019143631A1 (en) * 2018-01-16 2019-07-25 Phoenix Biomolecular Engineering Foundation Universal viral vaccines
KR20210043483A (en) * 2018-03-05 2021-04-21 온코이뮨, 아이앤씨. How to Use Soluble CD24 to Treat Acquired Immunodeficiency Syndrome (HIV/AIDS)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255555B1 (en) * 1997-04-17 2001-07-03 Japan Science And Technology Corporation Transgenic mouse expressing human fusin and human CD4
WO1999003888A1 (en) * 1997-07-17 1999-01-28 New York University Alternate receptors associated with retroviral entry into cells

Similar Documents

Publication Publication Date Title
AU2001250049A1 (en) Non-spherical whispering-gallery-mode microactivity
AU2002220843A1 (en) Humanised antibodies and uses thereof
AU1290001A (en) Antibodies
AU2001261630A1 (en) Audio closure
AU2001251486A1 (en) Aerosol enhancement device
AU2002213831A1 (en) Actuating member and method for producing the same
AU2001282890A1 (en) Immunosensor
AU2001296619A1 (en) Improved stopcock
AU2001239921A1 (en) Antibody inhibiting the binding between GP120 and DC-SIGN and screening methods
AU2001234125A1 (en) Antibody library
AU4935000A (en) Antibodies
AU2001280599A1 (en) Compounds and methods
EP1344576B8 (en) Inline sifter
AU2001253418A1 (en) Compounds and methods
IL206832A0 (en) Antibodies binding an 161p2f10b epitope and uses thereof
AU2002365649A1 (en) Anti-dota antibody
EP1469316A2 (en) Screening method
AU2002231295A1 (en) Developed seed and methods for making the same
AU2001243394A1 (en) Compounds and methods
AU2001296709A1 (en) Gemstone
AU2002223963A1 (en) Transaction certification
AUPQ872300A0 (en) Compounds and methods
AU2001294274A1 (en) Antibody inhibiting VPLF activity
AU2001295582A1 (en) Tumour-related antigens
AU2001278951A1 (en) Compounds and methods